Background While numerous studies have investigated short-term outcomes after
pulmonary embolism (PE), long-term mortality remains insufficiently studied. Objectives To …

OBJECTIVES: Systemic thrombolysis improves outcomes in patients with pulmonary
embolism (PE) but is associated with the risk of hemorrhage. The data on efficacy and safety …

Background The optimal therapy of patients with acute subsegmental pulmonary embolism
(PE) is controversial. Methods We used the RIETE (Registro Informatizado Enfermedad …

Mycoplasma is one of the most common pathogens causing community‑acquired
pneumonia in pediatric patients. In recent years, the number of refractory or severe cases …

Direct oral anti–activated factor X and antithrombin agents have largely replaced vitamin K
antagonists as the standard of care in treatment of venous thromboembolism. However …

The patients with intermediate-high risk pulmonary embolism who have acute right
ventricular (RV) dysfunction and myocardial injury without overt hemodynamic compromise …

The presence and severity of right ventricular (RV) dysfunction is a key determinant of
prognosis in the acute phase of pulmonary embolism (PE). Risk-adapted treatment …

Purpose To report 90-day results from the first interim analysis of the STRIKE-PE study,
which is evaluating safety, effectiveness, and functional and quality of life (QoL) outcomes of …

Objectives: This study aimed to evaluate the incidence and clinical outcomes of abnormal
ventilation/perfusion (V/Q) single-photon emission computed tomography (SPECT) without …

Introduction Acute pulmonary embolism (PE) is a major cause of morbidity and mortality in
Portugal. It is the third most common cause of cardiovascular death after stroke and …